Co-design and feasibility of a pharmacist-led minor ailment service

Dineen-Griffin, S; Benrimoj, SI; Williams, KA; Garcia-Cardenas, V

Co-design and feasibility of a pharmacist-led minor ailment service

Dineen-Griffin, S

Benrimoj, SI Williams, KA Garcia-Cardenas, V

Permalink

Publisher:: BioMed Central
Publication Type:: Journal Article
Citation:: BMC Health Services Research, 2021, 21, (1)
Issue Date:: 2021-01-22

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download full textAdobe PDF (2.07 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Dineen-Griffin, S https://orcid.org/0000-0001-7080-0108
dc.contributor.author	Benrimoj, SI
dc.contributor.author	Williams, KA
dc.contributor.author	Garcia-Cardenas, V
dc.date.accessioned	2021-09-14T01:35:42Z
dc.date.available	2021-01-12
dc.date.available	2021-09-14T01:35:42Z
dc.date.issued	2021-01-22
dc.identifier.citation	BMC Health Services Research, 2021, 21, (1)
dc.identifier.issn	1472-6963
dc.identifier.issn	1472-6963
dc.identifier.uri	http://hdl.handle.net/10453/150523
dc.description.abstract	<h4>Background</h4>Community pharmacies provide an appropriate setting to deliver minor ailment services (MASs). Many community pharmacy services have been developed previously without stakeholder involvement. As a result, implementation of services may fail to produce the expected impact. The aim of this research was to co-design and test the feasibility of an Australian MAS for minor ailment presentations.<h4>Methods</h4>This study used co-design methodology which included two phases: (1) a focus group with stakeholders to allow the conceptualization of the service and agreement on service elements; (2) a literature review of clinical guidelines and three working meetings with a team of editors and general practitioners for the development of treatment pathways. Following this, a study evaluating the feasibility of the co-designed service was undertaken. The qualitative part of the methodology associated with the feasibility study comprised semi-structured interviews with MAS pharmacists, observation and completion of a tool by change facilitators identifying barriers and facilitators to service delivery. Qualitative data obtained for all phases were analysed using thematic analysis.<h4>Results</h4>The developed service included the following components: (i) an in-pharmacy consultation between the patient and pharmacist, (ii) treatment pathways accessible to pharmacists on the internet to guide consultations, (iii) existing digital communication systems used by general practice to exchange patient information, (iv) training, and (v) change facilitation. As a result of feasibility testing, twenty-six implementation factors were identified for practice change, with the main change being the simplification of the pharmacist-patient consultation and data collection processes.<h4>Conclusions</h4>An Australian MAS was generated as a result of co-design, while testing revealed that the co-designed service was feasible. As a result of integrating the views of multiple stakeholders, the designed MAS has been adapted to suit healthcare practices, which may increase the acceptance and impact of MAS when implemented into practice.
dc.format	Electronic
dc.language	eng
dc.publisher	BioMed Central
dc.relation.ispartof	BMC Health Services Research
dc.relation.isbasedon	10.1186/s12913-021-06076-1
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	0807 Library and Information Studies, 1110 Nursing, 1117 Public Health and Health Services
dc.subject.classification	Health Policy & Services
dc.subject.mesh	Humans
dc.subject.mesh	Focus Groups
dc.subject.mesh	Feasibility Studies
dc.subject.mesh	Professional Role
dc.subject.mesh	Pharmacists
dc.subject.mesh	Community Pharmacy Services
dc.subject.mesh	Australia
dc.subject.mesh	Australia
dc.subject.mesh	Community Pharmacy Services
dc.subject.mesh	Feasibility Studies
dc.subject.mesh	Focus Groups
dc.subject.mesh	Humans
dc.subject.mesh	Pharmacists
dc.subject.mesh	Professional Role
dc.title	Co-design and feasibility of a pharmacist-led minor ailment service
dc.type	Journal Article
utslib.citation.volume	21
utslib.location.activity	England
utslib.for	0807 Library and Information Studies
utslib.for	1110 Nursing
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy
utslib.copyright.status	open_access	*
pubs.consider-herdc	false
dc.date.updated	2021-09-14T01:35:37Z
pubs.issue	1
pubs.publication-status	Published
pubs.volume	21
utslib.citation.issue	1

Abstract:

Background

Community pharmacies provide an appropriate setting to deliver minor ailment services (MASs). Many community pharmacy services have been developed previously without stakeholder involvement. As a result, implementation of services may fail to produce the expected impact. The aim of this research was to co-design and test the feasibility of an Australian MAS for minor ailment presentations.

Methods

This study used co-design methodology which included two phases: (1) a focus group with stakeholders to allow the conceptualization of the service and agreement on service elements; (2) a literature review of clinical guidelines and three working meetings with a team of editors and general practitioners for the development of treatment pathways. Following this, a study evaluating the feasibility of the co-designed service was undertaken. The qualitative part of the methodology associated with the feasibility study comprised semi-structured interviews with MAS pharmacists, observation and completion of a tool by change facilitators identifying barriers and facilitators to service delivery. Qualitative data obtained for all phases were analysed using thematic analysis.

Results

The developed service included the following components: (i) an in-pharmacy consultation between the patient and pharmacist, (ii) treatment pathways accessible to pharmacists on the internet to guide consultations, (iii) existing digital communication systems used by general practice to exchange patient information, (iv) training, and (v) change facilitation. As a result of feasibility testing, twenty-six implementation factors were identified for practice change, with the main change being the simplification of the pharmacist-patient consultation and data collection processes.

Conclusions

An Australian MAS was generated as a result of co-design, while testing revealed that the co-designed service was feasible. As a result of integrating the views of multiple stakeholders, the designed MAS has been adapted to suit healthcare practices, which may increase the acceptance and impact of MAS when implemented into practice.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/150523